Transaction Reports Krung Thai Bank
Krung Thai Bank PCL $1.2bn Rights Offering
Hunton & William’s Bangkok office recently advised Krung Thai Bank PCL, the largest state owned financial institution in Thailand, on its $1.2 billion rights offering, and its first capital increase in 13 years. The rights offering was unique in many respects, being: the first share offering by a Thai bank (or any Thai issuer) under Rule 801 of the US Securities Laws; the largest ever rights offering in history by a Thai corporate, and the largest public share offering by a Thai bank since the 1997 Asian financial crisis. The rights offering was successfully subscribed in full by the Bank’s existing shareholders.
Krung Thai Bank PCL began its operation on 14 March 1966 through the merger of business between the Agricultural Bank Limited and the Provincial Bank Limited with the Ministry of Finance as its major shareholder. The bank was then named Krung Thai Bank Limited and enjoyed the juristic person status of a state enterprise, attached to the Ministry of Finance. "Wayupak Bird", the official seal of the Ministry of Finance was thus adopted as the bank's logo. In the early stage of founding the bank had Bt 4,442.2 million in deposits, Bt 4,582.1 million in worth of assets, Bt 105 million in registered capital, 81 branches and 1,247 personnel.
Krung Thai
Bank Pcl $1.2bn Rights Offering
Legal advisor to Krung Thai Bank:
Metrics
Mayne Pharma Group Acquisition of Metrics, Inc
Mayne Pharma Group Limited is pleased to announce that it has entered into a binding agreement to acquire Metrics, Inc. (Metrics), a privately-owned, US-based provider of contract development services to the pharma industry that also develops and manufactures niche generic pharmaceuticals.
Consideration for the acquisition will comprise an upfront payment of US$105m plus further payments of up to US$15m based on FY13 performance (12 months ended 30 June 2013).
Metrics is a privately-owned specialty pharmaceutical company based in Greenville, North Carolina with approximately 300 employees. Metrics develops and manufactures niche generic drugs and is also a provider of contract
development services to the pharma industry.
Mayne Pharma’s CEO, Mr Scott Richards said “Metrics is highly complementary to Mayne Pharma’s existing business in term of its products, services and the markets in which it operates. In addition to providing scale in the US market, Metrics brings additional technical capabilities and material upside from cross-selling revenue opportunities. We have known Metrics’ senior management team for some time and they have a solid track record of success in the US generics industry.”
Miller & Martin PLLC attorney Joe DeLisle led the team that served as counsel to Mayne Pharma. Minter Ellison attorneys Nick Broome and Peter Kay represented Mayne Pharma on the Australian and corporate aspects of the transaction.
Legal advisor to Metrics, Inc: Mayne Pharma
Group Acquisition of Metrics, Inc
Legal advisors to Mayne Pharma Group:
Legal advisor to underwriters:
120
These announcements appears as a matter of record only